Abstract:Background and ObjectiveHuman periodontal ligament cells (hPDLCs) are considered the promising seed cells in periodontal tissue engineering. Previous studies have discovered the ability of hPDLCs in alveolar bone formation. It remains unclear, however, how the expression of factors associated with osteoclastogenesis in hPDLCs change during their osteogenic differentiation.ObjectiveThe present study aimed to observe the regulation of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in hPDLCs during their osteogenic differentiation.Material and MethodshPDLCs were treated with (M group) or without (C group) the osteogenic induction medium. Alkaline phosphatase activity was displayed with the Gomori calcium phosphate method. Mineralized nodules were detected with von Kossa staining. Expression levels of RANKL and OPG in hPDLCs were analyzed with real-time reverse transcription-polymerase chain reaction and western blot. Tartrate-resistant acid phosphatase (TRAP) staining was used to display the TRAP activity in Raw264.7 cells co-cultured with hPDLCs in the M group and the C group.ResultsWe found that alkaline phosphatase staining was shown to be remarkably higher in the M group than that in the C group during the 21d interval. Mineralized nodules could be seen in the M group but not in the C group. The expression levels of RANKL mRNA significantly decreased in the M group by 1.69-fold (p=0.096) at day 7, by 2.04-fold (p=0.000) at day 14 and by 1.84-fold (p=0.023) at day 21, compared with the corresponding levels of RANKL in the C group. Similarly, the levels of RANKL protein decreased in the M group by 1.82-fold (p=0.062) at day 7, by 5.64-fold (p=0.000) at day 14 and by 4.84-fold (p=0.000) at day 21. The mRNA and protein expression levels of OPG tended to increase in the M group. As a result, the RANKL/OPG mRNA and protein ratios were significantly downregulated by osteogenic induction. In addition, the number of TRAP staining-positive multinuclear cells in the M group was significantly less than in the C group (p=0.018).ConclusionhPDLCs may help inhibit the resorption of alveolar bone during their osteogenic differentiation by reducing the RANKL expression and the RANKL/OPG ratio.

[Expression of OPG and RANKL at Protein Level in Human Periodontal Ligament Cells and the Effect of 1alpha,25(oh)(2) Vitamin D(3) on the Secretion of OPG Protein in Vitro].

The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1α,25-dihydroxyvitamin D3

The Semi-Quantitative RT-PCR Study on the Expression of OPG and RANKL in Human Periodontal Ligament Cells Induced by 1alpha, 25 (OH)2 Vitamin D3

Effect of 1,25-(OH)2 D3 on the expression of amelogenin and ameloblastin secreted by porcine ameloblasts

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells.

Effects of Calcitriol on the Expression of Vitamin D Receptor. RANKL and Osteoprotegerin in Human Periodontal Ligament Cells

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Downregulation of Rankl and Rankl/Osteoprotegerin Ratio in Human Periodontal Ligament Cells During Their Osteogenic Differentiation

Effect of 1,25(OH)2D3 on the Expression of RANKL and Osteoprotegerin Mrna in Primary Rat Osteoblasts

Effect of 1α, 25-Dihydroxyvitamin D3 on the Osteogenic Differentiation of Human Periodontal Ligament Stem Cells and the Underlying Regulatory Mechanism.

Effects of IL-1β on OPG and RANKL mRNA expression in human periodontal ligament fibroblasts

1,25(OH)2D3 Supports the Osteogenic Differentiation of Hpdlscs under Inflammatory Conditions Through Inhibiting PLAP-1 Expression Transcriptionally.

Effects of Osteoblastic Growth Peptide on the Proliferation and Total Protein Content in Cultured Human Periodontal Ligament Cells

[Insulin-Like Growth Factor-Ii and Basic Fibroblast Growth Factor Affect Periodontal Ligament Cells Expressing Osteoprotegerin in Vitro].

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

1?,25-dihydroxyvitamin D3 promotes early osteogenic differentiation of PDLSCs and a 12-year follow-up case of early-onset vitamin D deficiency periodontitis

[The Effects of 1Alpha,25-Dihydroxyvitamin D3 in Regulation Matrix Metalloproteinase and Tissue Metalloproteinase Inhibitors in Human Osteoblasts].

[Expression of Osterix Mrna and Protein Induced by Recombinant Human Bone Morphogenetic Protein-2 in Human Periodontal Ligament Cells].

Characterization Of The Autocrine/Paracrine Function Of Vitamin D In Human Gingival Fibroblasts And Periodontal Ligament Cells

[Tumor Necrosis Factor and Lipopolysaccharide Affect Periodontal Ligament Cells Expressing Osteoprotegerin in Vitro].

Extending the Vitamin D Pathway to Vitamin D3 and CYP27A1 in Periodontal Ligament Cells